Evidence map›Paper›PMID 31791345›Full record

ArticleReproductive biology and endocrinology : RB&E2019

Molecular analysis of the effects of steroid hormones on mouse meiotic prophase I progression.

Deion M Burks, Margaret R McCoy, Sudipta Dutta, Connie J Mark-Kappeler, Patricia B Hoyer, Melissa E Pepling

Open access · goldAbstract read
In one paragraph

Article in Reproductive biology and endocrinology : RB&E, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Regulation of Meiotic Prophase One in Mammalian Oocytes.Frontiers in cell and developmental biology · 2021
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Deion M BurksDepartment of Biology, Syracuse University, 107 College Place, Syracuse, NY, 13244, USA.
Margaret R McCoyDepartment of Biology, Syracuse University, 107 College Place, Syracuse, NY, 13244, USA.
Sudipta DuttaDepartment of Biology, Syracuse University, 107 College Place, Syracuse, NY, 13244, USA.
Connie J Mark-KappelerDepartment of Physiology, College of Medicine, The University of Arizona, Tucson, AZ, USA.
Patricia B HoyerDepartment of Physiology, College of Medicine, The University of Arizona, Tucson, AZ, USA.
Melissa E PeplingDepartment of Biology, Syracuse University, 107 College Place, Syracuse, NY, 13244, USA. mepeplin@syr.edu.ORCID http://orcid.org/0000-0002-3789-5157
Syracuse University · USUniversity of Arizona · USUniversity of Nebraska Medical Center · US

Funding

Regulation of Primordial Follicle Formation and Oocyte SurvivalR15HD075257 · NICHD · SYRACUSE UNIVERSITY · PI PEPLING, MELISSA E · 2015 to 2015
$440k
NICHD NIH HHS R15 HD075257NIH HHS R15HD075257
6 · The paper itself

Abstract

backgroundInfertility is linked to depletion of the primordial follicle pool consisting of individual oocytes arrested at the diplotene stage of meiotic prophase I surrounded by granulosa cells. Primordial germ cells, the oocyte precursors, begin to differentiate during embryonic development. These cells migrate to the genital ridge and begin mitotic divisions, remaining connected, through incomplete cytokinesis, in clusters of synchronously dividing oogonia known as germ cell cysts. Subsequently, they enter meiosis, become oocytes and progress through prophase I to the diplotene stage. The cysts break apart, allowing individual oocytes to be surrounded by a layer of granulosa cells, forming primordial follicles each containing a diplotene arrested oocyte. A large number of oocytes are lost coincident with cyst breakdown, and may be important for quality control of primordial follicle formation. Exposure of developing ovaries to exogenous hormones can disrupt cyst breakdown and follicle formation, but it is unclear if hormones affect progression of oocytes through prophase I of meiosis.

methodsFetal ovaries were treated in organ culture with estradiol, progesterone, or both hormones, labeled for MSY2 or Synaptonemal complex protein 3 (SYCP3) using whole mount immunocytochemistry and examined by confocal microscopy. Meiotic prophase I progression was also followed using the meiotic surface spread technique.

resultsMSY2 expression in oocytes was reduced by progesterone but not estradiol or the hormone combination. However, while MSY2 expression was upregulated during development it was not a precise marker for the diplotene stage. We also followed meiotic prophase I progression using antibodies against SYCP3 using two different methods, and found that the percent of oocytes at the pachytene stage peaked at postnatal day 1. Finally, estradiol and progesterone treatment together but not either alone in organ culture increased the percent of oocytes at the pachytene stage.

conclusionsWe set out to examine the effects of hormones on prophase I progression and found that while MSY2 expression was reduced by progesterone, MSY2 was not a precise diplotene stage marker. Using antibodies against SYCP3 to identify pachytene stage oocytes we found that progesterone and estradiol together delayed progression of oocytes through prophase I.

Indexed as

AnimalsCell Cycle ProteinsDNA-Binding ProteinsEstradiolFemaleFetusGene Expression Regulation, DevelopmentalGranulosa CellsMeiotic Prophase IMice, Inbred C57BLOocytesOrgan Culture TechniquesOvaryPachytene StagePregnancyProgesteroneCell Cycle ProteinsDNA-Binding ProteinsEstradiolProgesteroneRNA-Binding ProteinsSycp3 protein, mouseYbx2 protein, mouseDiplotene arrestFetal oocyte developmentMeiotic prophasePrimordial follicle formationSteroid hormones

Identifiers

PMID31791345
PMCPMC6886186
OpenAlexW2992699557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.